cyclophosphamide

Generic: cyclophosphamide

Labeler: sagent pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cyclophosphamide
Generic Name cyclophosphamide
Labeler sagent pharmaceuticals
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

cyclophosphamide 2 g/100mL

Manufacturer
Sagent Pharmaceuticals

Identifiers & Regulatory

Product NDC 25021-249
Product ID 25021-249_5ed11ef9-73c0-42d1-9cac-0fba10a1f991
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214529
Listing Expiration 2026-12-31
Marketing Start 2024-01-15

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 25021249
Hyphenated Format 25021-249

Supplemental Identifiers

RxCUI
1734917 1734919 1734921
UNII
8N3DW7272P

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cyclophosphamide (source: ndc)
Generic Name cyclophosphamide (source: ndc)
Application Number ANDA214529 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 2 g/100mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (25021-249-51) / 100 mL in 1 VIAL
source: ndc

Packages (1)

Ingredients (1)

cyclophosphamide (2 g/100mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "5ed11ef9-73c0-42d1-9cac-0fba10a1f991", "openfda": {"unii": ["8N3DW7272P"], "rxcui": ["1734917", "1734919", "1734921"], "spl_set_id": ["329b5a3a-c7b9-4b11-abf0-009719cdfb79"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (25021-249-51)  / 100 mL in 1 VIAL", "package_ndc": "25021-249-51", "marketing_start_date": "20240115"}], "brand_name": "Cyclophosphamide", "product_id": "25021-249_5ed11ef9-73c0-42d1-9cac-0fba10a1f991", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "product_ndc": "25021-249", "generic_name": "Cyclophosphamide", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cyclophosphamide", "active_ingredients": [{"name": "CYCLOPHOSPHAMIDE", "strength": "2 g/100mL"}], "application_number": "ANDA214529", "marketing_category": "ANDA", "marketing_start_date": "20240115", "listing_expiration_date": "20261231"}